PortViewPortView
Xylo Technologies logo

Xylo Technologies (MDGS) Stock Analysis

NASDAQHealthcareMedical - Devices

$2.36+10.28%
1-year price historyRange $1.52 – $6.70
52-week range$2.36
$1.54$7.17

What Xylo Technologies does

Xylo Technologies Ltd. operates as a technology-focused enterprise, providing a comprehensive range of medical devices and related products to international markets, encompassing the United States, Europe, Asia, and Israel. The company's diverse operations are organized into several distinct segments, including Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and other divisions. Among its medical innovations is the Medigus Ultrasonic Surgical Endostapler, an advanced endoscopy system specifically utilized for treating gastroesophageal reflux disease. Xylo Technologies also develops specialized biological gels, engineered to safeguard patients against biological threats and to minimize the intrusion of allergens and viruses through the upper respiratory passages and ocular areas. Beyond its healthcare offerings, the company maintains a significant presence in the digital sector. This includes furnishing a digital advertising platform, managing various online retail outlets for consumer products on the Amazon marketplace, and operating an online platform for event management and ticketing services. Furthermore, Xylo Technologies is actively engaged in pioneering wireless battery charging technologies for vehicles and developing modular electronic vehicles. The organization, which was previously known as Medigus Ltd., officially adopted its current name, Xylo Technologies Ltd., in April 2024. Established in 1999, the company maintains its corporate headquarters in Tel Aviv-Yafo, Israel.

Key metrics

Market cap
$178.86M
P/E (TTM)
-0.27
EPS (TTM)
$-8.70
Beta
1.37
Dividend yield
0.00%
Revenue / share
$41.42
50-day avg
$2.60
200-day avg
$3.29
52-week high
$7.17
52-week low
$1.54
CEO
Liron Carmel

ETFs linked to MDGS

Broad-market and Healthcare sector ETFs an investor holding Xylo Technologies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MDGS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MDGS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Xylo Technologies?
Xylo Technologies trades under the ticker MDGS on NASDAQ.
Which exchange is MDGS listed on?
MDGS is listed on NASDAQ.
What sector does Xylo Technologies operate in?
Xylo Technologies is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze MDGS in a portfolio?
PortView shows MDGS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.